Day: December 15, 2015

December 15, 2015 SOURCE: REGEN BIOPHARMA INC.

Regen BioPharma, Inc. Receives FDA Clearance to Initiate Clinical Trial of HemaXellerate. Company to initiate Phase I Clinical Trial for IMmune Modulatory Personalized Cell Therapy in Treatment of Aplastic Anemia.